Indevus licenses trospium XR’s Canadian rights to Allergan (PharmaBiz)
Indevus Pharmaceuticals, Inc. announced the signing of a license agreement with Allergan Inc., a Canadian affiliate of Allergan, Inc., based in Irvine, California, granting Allergan the right to market Sanctura XR (trospium chloride extended release preparation) throughout Canada.
More: continued here





